Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Liver Cirrhosis × Cannabidiol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Seizures 1 Neoplasms 1 Liver Cirrhosis 1 Lennox Gastaut Syndrome 1 Epilepsies, Myoclonic 1 Cancer Pain 1 Behavior 1 Anxiety Disorders 1

Interventions

Standard of Care 1 Control Groups 1 Cannabidiol 1 Anti-HIV Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05044819 2026-03-17

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡